Skip to main content
Erschienen in: Acta Diabetologica 1/2019

29.08.2018 | Original Article

Autonomic testing: which value for each cardiovascular test? An observational study

verfasst von: Federico Bellavere, Eugenio Ragazzi, Nino Cristiano Chilelli, Annunziata Lapolla, Giuseppe Bax

Erschienen in: Acta Diabetologica | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Aims

Cardiovascular autonomic testing is time consuming when adopting the entire Ewing battery of tests, hence, clinicians usually adopt an empirically reduced number of tests which may give controversial results. Our purpose was to examine the reliability of the cardiovascular tests most commonly used in autonomic diagnoses.

Methods

We tested 334 subjects, from an original group of 3745, who had shown an altered deep breathing test to both Lying to standing and Valsalva manoeuvre, assuming a value of postural hypotension of more than 15 mmHg as a sign of almost true dysautonomia.

Results

VM showed the highest sensitivity (85%) and, when coupled to LS, highest specificity (83%).

Conclusions

VM could be useful when screening for possible or early autonomic neuropathy, VM + LS is useful as a diagnostic tool for probable or advanced autonomic neuropathy, and VM + LS + PH is useful for certain diagnosis of definite or late stage autonomic neuropathy.
Literatur
1.
Zurück zum Zitat Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579CrossRef Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579CrossRef
2.
Zurück zum Zitat Wheeler T, Watkins PJ (1973) Cardiac denervation in diabetes. Br Med J 8:584–586.CrossRef Wheeler T, Watkins PJ (1973) Cardiac denervation in diabetes. Br Med J 8:584–586.CrossRef
3.
Zurück zum Zitat Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropahy. Br Med J. 285:916–918CrossRef Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropahy. Br Med J. 285:916–918CrossRef
4.
Zurück zum Zitat Bellavere F, Bosello G, Fedele D, Cardone C, Ferri M (1983) Diagnosis and management of diabetic autonomic neuropathy. Br Med J 287:61CrossRef Bellavere F, Bosello G, Fedele D, Cardone C, Ferri M (1983) Diagnosis and management of diabetic autonomic neuropathy. Br Med J 287:61CrossRef
5.
Zurück zum Zitat Spallone V, Bellavere F, Scionti L et al (2010) Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. Nutr Metab Cardiovasc Dis 21:69–78CrossRef Spallone V, Bellavere F, Scionti L et al (2010) Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. Nutr Metab Cardiovasc Dis 21:69–78CrossRef
6.
Zurück zum Zitat Bellavere F (1995) Heart rate variability in patients with diabetes and other non cardiological diseases. In: Malik M, Camm AJ (eds) Heart rate variability. Futura Publishing Co., Armonk, pp 507–516 Bellavere F (1995) Heart rate variability in patients with diabetes and other non cardiological diseases. In: Malik M, Camm AJ (eds) Heart rate variability. Futura Publishing Co., Armonk, pp 507–516
7.
Zurück zum Zitat Ewing DJ, Campbell IW, Clarke BF (1976) Mortality in diabetic autonomic neuropathy. Lancet 1:601–603CrossRefPubMed Ewing DJ, Campbell IW, Clarke BF (1976) Mortality in diabetic autonomic neuropathy. Lancet 1:601–603CrossRefPubMed
9.
Zurück zum Zitat Lykke JA, Tarnow L, Parving H-H, Hilsted J (2008) A combined abnormality in heart rate variation and QT corrected interval is a strong predictor of cardiovascular death in type 1 diabetes. Scan J Clin Lab Invest 68:654–659CrossRef Lykke JA, Tarnow L, Parving H-H, Hilsted J (2008) A combined abnormality in heart rate variation and QT corrected interval is a strong predictor of cardiovascular death in type 1 diabetes. Scan J Clin Lab Invest 68:654–659CrossRef
10.
Zurück zum Zitat Young LH, Wackers FJ, Chyun DA et al (2009) Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes. The DIAD study: a randomized controlled trial. J Am Med Assoc 301:1547–1555CrossRef Young LH, Wackers FJ, Chyun DA et al (2009) Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes. The DIAD study: a randomized controlled trial. J Am Med Assoc 301:1547–1555CrossRef
11.
Zurück zum Zitat (1983) Editorial: diabetic neuropathy: where are we now? Lancet:1366–1367 (1983) Editorial: diabetic neuropathy: where are we now? Lancet:1366–1367
12.
Zurück zum Zitat Bellavere F, Balzani I, De Masi G et al (1991) Power spectral analysis of heart-rate variations improves assessment of diabetic cardiac autonomic neuropathy. Diabetes 41:633–640CrossRef Bellavere F, Balzani I, De Masi G et al (1991) Power spectral analysis of heart-rate variations improves assessment of diabetic cardiac autonomic neuropathy. Diabetes 41:633–640CrossRef
13.
Zurück zum Zitat Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043–1065CrossRef Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043–1065CrossRef
14.
Zurück zum Zitat Tang ZH, Wang L, Zeng F et al (2014) Bayesian estimation of cardiovascular autonomic neuropathy diagnostic test based on short term heart rate variability without a gold standard. BMJ Open 4(9):e005096CrossRefPubMedPubMedCentral Tang ZH, Wang L, Zeng F et al (2014) Bayesian estimation of cardiovascular autonomic neuropathy diagnostic test based on short term heart rate variability without a gold standard. BMJ Open 4(9):e005096CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Vinik AI, Ziegler D (2007) Diabetic cardiovascular autonomic neuropathy. Circulation 115:387–397CrossRefPubMed Vinik AI, Ziegler D (2007) Diabetic cardiovascular autonomic neuropathy. Circulation 115:387–397CrossRefPubMed
16.
Zurück zum Zitat Chyun DA, Wackers FJ, Inzucchi SE et al (2015) Autonomic dysfunction independently predicts poor cardiovascular outcomes in asymptomatic individuals with type 2 diabetes in the DIAD study. SAGE Open Med 3:2050312114568476CrossRefPubMedPubMedCentral Chyun DA, Wackers FJ, Inzucchi SE et al (2015) Autonomic dysfunction independently predicts poor cardiovascular outcomes in asymptomatic individuals with type 2 diabetes in the DIAD study. SAGE Open Med 3:2050312114568476CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Cha SA, Yun JS, Lim TS et al (2016) Diabetic cardiovascular autonomic neuropathy predicts recurrent cardiovascular diseases in patients with type 2 diabetes. PLoS One 11(10):e0164807CrossRefPubMedPubMedCentral Cha SA, Yun JS, Lim TS et al (2016) Diabetic cardiovascular autonomic neuropathy predicts recurrent cardiovascular diseases in patients with type 2 diabetes. PLoS One 11(10):e0164807CrossRefPubMedPubMedCentral
Metadaten
Titel
Autonomic testing: which value for each cardiovascular test? An observational study
verfasst von
Federico Bellavere
Eugenio Ragazzi
Nino Cristiano Chilelli
Annunziata Lapolla
Giuseppe Bax
Publikationsdatum
29.08.2018
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 1/2019
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-018-1215-y

Weitere Artikel der Ausgabe 1/2019

Acta Diabetologica 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.